Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Epax Receives Frost & Sullivan Product Differentiation Excellence Award - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Epax Receives Frost & Sullivan Product Differentiation Excellence Award

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The Frost & Sullivan Product Differentiation Excellence Award has honored Oslo, Norway’s Epax for its condition-specific range of concentrated EPA/DHA omega 3 ingredient products and the company’s success in carving out a niche in a crowded market.
“Product differentiation is one of the prime factors that define success in the omega-3 market,” said Frost & Sullivan research analyst, Ashwin Raj Ravinder. “Epax abides by the strictest norms, right from choosing the raw material to final delivery, and they consistently deliver products with the best purity profile in the industry.”
The Epax product range contains an optimum EPA and DHA ratio that offers a cost-effective solution. Multiple clinical studies and the European Food Safety Authority (EFSA) approved health claims strengthen Epax’s marketability and presence.
Epax also received Frost & Sullivan’s Excellence in Product Quality Award in 2008. 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics